LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. Recommended Stories Federal judge temporarily halts Paramount-Warner Bros. merger Trump media asks for $100,000 per month for rapid access to Truth posts Truth Social to offer banks ‘fastest’ access to market-moving Trump posts